Prozac, a common medication used to combat depression, has been found to be less effective on patients with a specific gene set. People who have taken Prozac for two months but have shown no sign of improvement should opt for another treatment, says a medical report released by the Taipei Veterans General Hospital (TVGH). Tsai Shih-jen (蔡世仁), section chief of General Psychiatry at TVGH, said those with major depression carry genes that mitigate serotonin reuptake transporters, enhance monoamine oxidase, disrupt brain-derived neurotrophic factors, or generate serotonin 1A receptors that are more likely to be "Prozac-resistant."
Fri, Nov 17, 2006 - Page 3 News List
Taiwan Quick Take: Limitations found for Prozac
STAFF WRITER WITH AGENCIES
This story has been viewed 2015 times.
Listing from 2015-05-20 to 2015-05-27
- Most read
- Most e-mailed
1LG aims for wider market share with flagship G4 launch
2Swiss go ‘smart’ to rein in Apple
3Nuclear power not cheap, being phased out: expert
4Six Chinese face US economic theft case
5Greenpeace study finds China illegally fishing in Africa